Country: United States
Language: English
Source: NLM (National Library of Medicine)
VANCOMYCIN HYDROCHLORIDE (UNII: 71WO621TJD) (VANCOMYCIN - UNII:6Q205EH1VU)
Pfizer Laboratories Div Pfizer Inc
VANCOMYCIN HYDROCHLORIDE
VANCOMYCIN 5 g in 100 mL
PRESCRIPTION DRUG
Abbreviated New Drug Application
STERILE VANCOMYCIN HYDROCHLORIDE- VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PFIZER LABORATORIES DIV PFIZER INC ---------- STERILE VANCOMYCIN HYDROCHLORIDE, USP RX ONLY PHARMACY BULK PACKAGE - NOT FOR DIRECT INFUSION To reduce the development of drug-resistant bacteria and maintain the effectiveness of vancomycin and other antibacterial drugs, vancomycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION Sterile Vancomycin Hydrochloride, USP is a lyophilized powder, for preparing intravenous (IV) infusions. Each Pharmacy Bulk Package contains vancomycin hydrochloride equivalent to 5 grams of vancomycin base. When reconstituted as directed each 10 mL contains 500 mg and each 20 mL contains 1 gram. Vancomycin hydrochloride is an off-white to tan colored lyophilized powder. It may contain hydrochloric acid and/or sodium hydroxide for pH adjustment. When reconstituted with Sterile Water for Injection, USP it forms a clear solution with the pH of the solution between 2.5 and 4.5. This product is oxygen sensitive. This Pharmacy Bulk Package is a sterile preparation for intravenous use that contains many single doses. The contents are intended for use in a pharmacy admixture service. Vancomycin hydrochloride is prepared as a solution and lyophilized in its final container. Vancomycin is a tricyclic glycopeptide antibiotic derived from_ Amycolatopsis orientalis _(formerly _Nocardia orientalis_). The molecular formula is C H Cl N O •HCl and the molecular weight is 1,485.71. Vancomycin Hydrochloride has the following chemical designation: (_S_)-(3_S_,6_R,_7 _R,_22_R,_23_S_,26_S_,36_R,_38a_R_)-44-[[2-_O_-(3-Amino- 2,3,6-trideoxy-3-_C_-methyl-α-L-_lyxo_- hexopyranosyl)-β-D-glucopyranosyl]oxy]-3-(carbamoylmethyl)-10,19-dichloro- 2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro- 7,22,28,30,32-pentahydroxy-6-[(2_R_)-4-methyl-2- (methylamino)]valeramido]-2,5,24,38,39-pentaoxo-22_H_-8,11:18,21-dietheno-23,36-(iminomethano Read the complete document